FIREFLY NEUROSCIENCE INC (AIFF) Stock News

NASDAQ:AIFF - Nasdaq - US3179701012 - Common Stock - Currency: USD

2.51 -0.14 (-5.28%)

After market: 2.4701 -0.04 (-1.59%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AIFF Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Firefly Neuroscience, Inc.

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

2 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience to be Added to the Russell Microcap® Index

2 months ago - By: Benzinga - Mentions: RGC SMLR GLMD IRD ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

7 months ago - By: Benzinga

What's Going On With Firefly Neuroscience Stock Tuesday?

2 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

4 months ago - By: Firefly Neuroscience, Inc.

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

4 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

6 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

6 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Accepted into NVIDIA Connect Program

6 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

7 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care

7 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

8 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Closes on Financing of up to $12.4 Million

9 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

9 months ago - By: Firefly Neuroscience, Inc.

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update